KROS
Price
$15.04
Change
+$0.16 (+1.08%)
Updated
Oct 24 closing price
Capitalization
458.21M
3 days until earnings call
Intraday Buy/Sell Signals
SPRY
Price
$9.11
Change
-$0.54 (-5.60%)
Updated
Oct 24 closing price
Capitalization
900.31M
10 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

KROS vs SPRY

Header iconKROS vs SPRY Comparison
Open Charts KROS vs SPRYBanner chart's image
Keros Therapeutics
Price$15.04
Change+$0.16 (+1.08%)
Volume$703.28K
Capitalization458.21M
ARS Pharmaceuticals
Price$9.11
Change-$0.54 (-5.60%)
Volume$1.92M
Capitalization900.31M
KROS vs SPRY Comparison Chart in %
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. SPRY commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and SPRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (KROS: $15.04 vs. SPRY: $9.11)
Brand notoriety: KROS and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 106% vs. SPRY: 70%
Market capitalization -- KROS: $458.21M vs. SPRY: $900.31M
KROS [@Biotechnology] is valued at $458.21M. SPRY’s [@Biotechnology] market capitalization is $900.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • KROS’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, KROS is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 3 bullish TA indicator(s).

  • KROS’s TA Score: 6 bullish, 4 bearish.
  • SPRY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KROS is a better buy in the short-term than SPRY.

Price Growth

KROS (@Biotechnology) experienced а +8.75% price change this week, while SPRY (@Biotechnology) price change was -9.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($900M) has a higher market cap than KROS($458M). SPRY has higher P/E ratio than KROS: SPRY (151.25) vs KROS (47.00). KROS YTD gains are higher at: -4.991 vs. SPRY (-13.649). KROS has higher annual earnings (EBITDA): 25.5M vs. SPRY (-59.34M). KROS has more cash in the bank: 690M vs. SPRY (240M). SPRY has less debt than KROS: SPRY (1.66M) vs KROS (18M). KROS has higher revenues than SPRY: KROS (233M) vs SPRY (112M).
KROSSPRYKROS / SPRY
Capitalization458M900M51%
EBITDA25.5M-59.34M-43%
Gain YTD-4.991-13.64937%
P/E Ratio47.00151.2531%
Revenue233M112M208%
Total Cash690M240M288%
Total Debt18M1.66M1,084%
TECHNICAL ANALYSIS
Technical Analysis
KROSSPRY
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSMVX28.520.22
+0.78%
Wilshire Small Company Value Instl
LAFAX29.870.16
+0.54%
Columbia Acorn International Sel A
BMECX15.390.08
+0.52%
BlackRock High Equity Income Investor C
CHVCX14.190.07
+0.50%
Cullen High Dividend Equity C
MIDBX32.120.11
+0.34%
MFS International New Discovery B

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+1.08%
INO - KROS
53%
Loosely correlated
+3.56%
AXON - KROS
43%
Loosely correlated
+2.73%
RAPT - KROS
39%
Loosely correlated
-1.57%
DNLI - KROS
39%
Loosely correlated
+0.50%
ALT - KROS
39%
Loosely correlated
-0.25%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-5.60%
LPCN - SPRY
63%
Loosely correlated
+3.94%
ANAB - SPRY
35%
Loosely correlated
+3.15%
KROS - SPRY
34%
Loosely correlated
+1.08%
REPL - SPRY
31%
Poorly correlated
+4.51%
ZBIO - SPRY
30%
Poorly correlated
-4.46%
More